Itopride hydrochloride

盐酸伊托必利

Report date: 2024/04/28 17:06:38
NME

Base Information

Drug NameItopride hydrochloride
Drug Alias Nameitoprida盐酸依托必利伊托必利itoprideitopridum +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsNauseaHeartburnDyspepsia +[9] 
Global Approved IndicationsGastrointestinal Diseases
Approved Indications in ChinaGastrointestinal Diseases
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryArmeniaCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbott Japan Llc
China Registration ClassN/A

Develop Information

Active CompaniesAbbott LaboratoriesOctober 6 UniversityLivzon Syntpharm Co Ltd (Zhuhaiftz) +[4] 
Inactive CompaniesShanghai Jiao Tong University School of MedicineForest Laboratories Inc
Active IndicationsNauseaDyspepsiaFatty Liver +[5] 
Inactive IndicationsHeartburnConstipationGastroparesis +[4] 

Other Information

ATC CodeA03FA07
Related LinksWikipediaDrugBankKEGG